Please enable JavaScript to continue using this application.

Compare $BHVN vs $SRPT | Chartloom

Compare

$BHVN vs $SRPT

Biohaven Ltd · Sarepta Therapeutics Inc

BHVN

Biohaven Ltd

SRPT

Sarepta Therapeutics Inc

Compare $BHVN vs $SRPT

Comparing Biohaven Ltd and Sarepta Therapeutics Inc

BHVNBiohaven Ltd

SRPTSarepta Therapeutics Inc

BHVNBiohaven Ltd

Market cap

$1.82B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

113.82x

Rev growth (TTM)

—

YTD performance

11.4%

52W performance

-21.3%

FCF yield

-28.1%

SRPTSarepta Therapeutics Inc

Market cap

$1.88B

P/E (TTM)

—

Forward P/E (NTM)

46.80x

Forward P/S (NTM)

1.31x

Rev growth (TTM)

-20.4%

YTD performance

-16.2%

52W performance

-23.7%

FCF yield

4.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BHVN

SRPT

Detailed metrics comparison

BHVN

Biohaven Ltd

SRPT

Sarepta Therapeutics Inc

Market Cap

BHVN$1.82B

SRPT$1.88B

Enterprise Value

BHVN$1.84B

SRPT$2.16B

Price

BHVN$12.08

SRPT$17.85

P/E Ratio

BHVNN/A

SRPTN/A

P/S Ratio

BHVN0.00x

SRPT0.95x

EV/Sales

BHVN0.00x

SRPT1.09x

EV/EBITDA

BHVN0.00x

SRPT12.13x

P/B Ratio

BHVN159.05x

SRPT1.21x

P/FCF Ratio

BHVNN/A

SRPT25.00x

EV/FCF

BHVN-3.60x

SRPT28.66x

PEG Ratio

BHVNN/A

SRPTN/A

Forward P/E (NTM)

BHVNN/A

SRPT46.80x

Forward P/S (NTM)

BHVN113.82x

SRPT1.31x

Revenue (TTM)

BHVN$0

SRPT$1.97B

Revenue Growth (YoY)

BHVNN/A

SRPT-20.4%

Forward Rev Growth

BHVN169.9%

SRPT-23.2%

Gross Margin (TTM)

BHVN0.0%

SRPT67.5%

Operating Margin (TTM)

BHVN0.0%

SRPT0.0%

EBITDA Margin (TTM)

BHVN0.0%

SRPT7.5%

Net Margin (TTM)

BHVN0.0%

SRPT-6.9%

FCF Margin (TTM)

BHVNN/A

SRPT3.8%

Net Income (TTM)

BHVN$-587M

SRPT$-137M

FCF (TTM)

BHVN$-512M

SRPT$75M

EPS (TTM)

BHVN-$3.90

SRPT-$1.30

ROE (TTM)

BHVN-63995.0%

SRPT-996.0%

ROA (TTM)

BHVN-13827.0%

SRPT-414.0%

ROIC (TTM)

BHVN-13277.0%

SRPT-605.0%

Cash

BHVN$238M

SRPT$571M

Debt

BHVN$259M

SRPT$848M

Net Cash/Debt

BHVN$-21M

SRPT$-276M

Current Ratio (TTM)

BHVN4.73x

SRPT4.42x

Quick Ratio (TTM)

BHVN4.30x

SRPT2.57x

Debt/Equity (TTM)

BHVN21.23x

SRPT0.55x

Debt/Assets (TTM)

BHVN0.0%

SRPT0.0%

Interest Coverage (TTM)

BHVNN/A

SRPTN/A

Net Debt/EBITDA (TTM)

BHVN0.00x

SRPT0.00x

Beta

BHVN3.18

SRPT0.46

52W Performance

BHVN-21.3%

SRPT-23.7%

YTD Performance

BHVN11.4%

SRPT-16.2%

% from 52W High

BHVN-34.9%

SRPT-27.7%

% from 52W Low

BHVN61.5%

SRPT21.6%

Asset Turnover (TTM)

BHVN0.00x

SRPT0.60x

FCF Yield (TTM)

BHVN-28.1%

SRPT4.0%

Earnings Yield (TTM)

BHVN-32.3%

SRPT-7.3%

Dividend Yield (TTM)

BHVNN/A

SRPTN/A

Rule of 40

BHVN0.0

SRPT-16.6

EV/GP/RG

BHVNN/A

SRPTN/A

Ticker research

View BHVN research View SRPT research

Metric	BHVN Biohaven Ltd	SRPT Sarepta Therapeutics Inc
Market & Valuation
Market Cap	$1.82B	$1.88B
Enterprise Value	$1.84B	$2.16B
Price	$12.08	$17.85
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.95x
EV/Sales	0.00x	1.09x
EV/EBITDA	0.00x	12.13x
P/B Ratio	159.05x	1.21x
P/FCF Ratio	N/A	25.00x
EV/FCF	-3.60x	28.66x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	46.80x
Forward P/S (NTM)	113.82x	1.31x
Revenue & Growth
Revenue (TTM)	$0	$1.97B
Revenue Growth (YoY)	N/A	-20.4%
Forward Rev Growth	169.9%	-23.2%
Profitability
Gross Margin (TTM)	0.0%	67.5%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	7.5%
Net Margin (TTM)	0.0%	-6.9%
FCF Margin (TTM)	N/A	3.8%
Net Income (TTM)	$-587M	$-137M
FCF (TTM)	$-512M	$75M
EPS (TTM)	-$3.90	-$1.30
ROE (TTM)	-63995.0%	-996.0%
ROA (TTM)	-13827.0%	-414.0%
ROIC (TTM)	-13277.0%	-605.0%
Financial Health
Cash	$238M	$571M
Debt	$259M	$848M
Net Cash/Debt	$-21M	$-276M
Current Ratio (TTM)	4.73x	4.42x
Quick Ratio (TTM)	4.30x	2.57x
Debt/Equity (TTM)	21.23x	0.55x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	3.18	0.46
52W Performance	-21.3%	-23.7%
YTD Performance	11.4%	-16.2%
% from 52W High	-34.9%	-27.7%
% from 52W Low	61.5%	21.6%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.60x
FCF Yield (TTM)	-28.1%	4.0%
Earnings Yield (TTM)	-32.3%	-7.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-16.6
EV/GP/RG	N/A	N/A
Ticker research	View BHVN research	View SRPT research

Valuation

P/S Ratio

BHVN

0.00x

SRPT

0.95x

EV/FCF

BHVN

-3.60x

SRPT

28.66x

Growth & revenue

Revenue Growth TTM

SRPT

-20.4%

Forward Revenue Growth

BHVN

169.9%

SRPT

-23.2%

Profitability & performance

Gross Margin

SRPT

67.5%

BHVN

0.0%

ROE

SRPT

-996.0%

BHVN

-63995.0%

FCF Yield %

SRPT

4.0%

BHVN

-28.1%

52-Week Performance

BHVN

-21.3%

SRPT

-23.7%

Detailed metrics comparison

BHVN

Biohaven Ltd

SRPT

Sarepta Therapeutics Inc

Market Cap

BHVN$1.82B

SRPT$1.88B

Enterprise Value

BHVN$1.84B

SRPT$2.16B

Price

BHVN$12.08

SRPT$17.85

P/E Ratio

BHVNN/A

SRPTN/A

P/S Ratio

BHVN0.00x

SRPT0.95x

EV/Sales

BHVN0.00x

SRPT1.09x

EV/EBITDA

BHVN0.00x

SRPT12.13x

P/B Ratio

BHVN159.05x

SRPT1.21x

P/FCF Ratio

BHVNN/A

SRPT25.00x

EV/FCF

BHVN-3.60x

SRPT28.66x

PEG Ratio

BHVNN/A

SRPTN/A

Forward P/E (NTM)

BHVNN/A

SRPT46.80x

Forward P/S (NTM)

BHVN113.82x

SRPT1.31x

Revenue (TTM)

BHVN$0

SRPT$1.97B

Revenue Growth (YoY)

BHVNN/A

SRPT-20.4%

Forward Rev Growth

BHVN169.9%

SRPT-23.2%

Gross Margin (TTM)

BHVN0.0%

SRPT67.5%

Operating Margin (TTM)

BHVN0.0%

SRPT0.0%

EBITDA Margin (TTM)

BHVN0.0%

SRPT7.5%

Net Margin (TTM)

BHVN0.0%

SRPT-6.9%

FCF Margin (TTM)

BHVNN/A

SRPT3.8%

Net Income (TTM)

BHVN$-587M

SRPT$-137M

FCF (TTM)

BHVN$-512M

SRPT$75M

EPS (TTM)

BHVN-$3.90

SRPT-$1.30

ROE (TTM)

BHVN-63995.0%

SRPT-996.0%

ROA (TTM)

BHVN-13827.0%

SRPT-414.0%

ROIC (TTM)

BHVN-13277.0%

SRPT-605.0%

Cash

BHVN$238M

SRPT$571M

Debt

BHVN$259M

SRPT$848M

Net Cash/Debt

BHVN$-21M

SRPT$-276M

Current Ratio (TTM)

BHVN4.73x

SRPT4.42x

Quick Ratio (TTM)

BHVN4.30x

SRPT2.57x

Debt/Equity (TTM)

BHVN21.23x

SRPT0.55x

Debt/Assets (TTM)

BHVN0.0%

SRPT0.0%

Interest Coverage (TTM)

BHVNN/A

SRPTN/A

Net Debt/EBITDA (TTM)

BHVN0.00x

SRPT0.00x

Beta

BHVN3.18

SRPT0.46

52W Performance

BHVN-21.3%

SRPT-23.7%

YTD Performance

BHVN11.4%

SRPT-16.2%

% from 52W High

BHVN-34.9%

SRPT-27.7%

% from 52W Low

BHVN61.5%

SRPT21.6%

Asset Turnover (TTM)

BHVN0.00x

SRPT0.60x

FCF Yield (TTM)

BHVN-28.1%

SRPT4.0%

Earnings Yield (TTM)

BHVN-32.3%

SRPT-7.3%

Dividend Yield (TTM)

BHVNN/A

SRPTN/A

Rule of 40

BHVN0.0

SRPT-16.6

EV/GP/RG

BHVNN/A

SRPTN/A

Ticker research

View BHVN research View SRPT research

Metric	BHVN Biohaven Ltd	SRPT Sarepta Therapeutics Inc
Market & Valuation
Market Cap	$1.82B	$1.88B
Enterprise Value	$1.84B	$2.16B
Price	$12.08	$17.85
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.95x
EV/Sales	0.00x	1.09x
EV/EBITDA	0.00x	12.13x
P/B Ratio	159.05x	1.21x
P/FCF Ratio	N/A	25.00x
EV/FCF	-3.60x	28.66x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	46.80x
Forward P/S (NTM)	113.82x	1.31x
Revenue & Growth
Revenue (TTM)	$0	$1.97B
Revenue Growth (YoY)	N/A	-20.4%
Forward Rev Growth	169.9%	-23.2%
Profitability
Gross Margin (TTM)	0.0%	67.5%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	7.5%
Net Margin (TTM)	0.0%	-6.9%
FCF Margin (TTM)	N/A	3.8%
Net Income (TTM)	$-587M	$-137M
FCF (TTM)	$-512M	$75M
EPS (TTM)	-$3.90	-$1.30
ROE (TTM)	-63995.0%	-996.0%
ROA (TTM)	-13827.0%	-414.0%
ROIC (TTM)	-13277.0%	-605.0%
Financial Health
Cash	$238M	$571M
Debt	$259M	$848M
Net Cash/Debt	$-21M	$-276M
Current Ratio (TTM)	4.73x	4.42x
Quick Ratio (TTM)	4.30x	2.57x
Debt/Equity (TTM)	21.23x	0.55x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	3.18	0.46
52W Performance	-21.3%	-23.7%
YTD Performance	11.4%	-16.2%
% from 52W High	-34.9%	-27.7%
% from 52W Low	61.5%	21.6%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.60x
FCF Yield (TTM)	-28.1%	4.0%
Earnings Yield (TTM)	-32.3%	-7.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-16.6
EV/GP/RG	N/A	N/A
Ticker research	View BHVN research	View SRPT research